Interleukin 17 (IL-17) and interleukin 23 (IL-23) levels are modulated by compressive orthodontic forces in humans

被引:5
|
作者
Allgayer, Susiane [1 ]
de Menezes, Luciane Macedo [2 ]
Batista, Eraldo L., Jr. [3 ]
机构
[1] Assoc Brasileira Odontol ABORS, Dept Orthodont, Rua Furriel Luis de Vargas 134, BR-90619900 Porto Alegre, RS, Brazil
[2] Pontificia Univ Catolica Rio Grande do Sul PUCRS, Dept Orthodont, Ave Ipiranga 6681, BR-90619900 Porto Alegre, RS, Brazil
[3] Univ Manitoba, Coll Dent, Fac Hlth Sci, Dept Diagnost & Surg Sci,Div Periodont,Dept Oral, Winnipeg, MB R3E 0W2, Canada
关键词
Biologic marker; Interleukin; Interleukin-17; Maxillary expansion; Orthodontic appliances; Th17; cells; GINGIVAL CREVICULAR FLUID; PERIODONTAL-LIGAMENT; TOOTH MOVEMENT; CELL-DIFFERENTIATION; ROOT RESORPTION; TH17; CELLS; EXPRESSION; CYTOKINES; KINETICS; SITES;
D O I
10.1016/j.ejwf.2019.06.001
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective: The purpose of the investigation was to evaluate whether the application of compression forces exerted on the periodontal ligament during orthodontic movement is reflected at the level of interleukin (IL)-17 and IL-23. Materials and methods: The gingival crevicular fluid (GCF) samples from the compression sites of 32 molars from 16 patients prescribed with modified Hyrax appliance were collected. The GCF were analyzed for IL-17, IL-23, and IL-1 beta (Control) at baseline and at 1, 7, and 14 days of active wear of the appliance. Results: Orthodontic forces resulted in increased levels of IL-17 and IL-23 in the GCF, which were statistically significant at 7 days of force application at compression sites. At day 14, levels decreased to baseline; IL-1 beta levels (positive control) were more elevated at all times after force application. IL-17 and IL-23 levels were significantly lower than IL-1D, and undetectable in some samples. Conclusion: Upregulation of IL-17 and IL-23 occurred in response to the force application in compression sites. Monitoring the levels of inflammatory mediators might be a clinically useful procedure, as they may help to define optimal forces to produce the most rapid tooth movement. (C) 2019 World Federation of Orthodontists.
引用
收藏
页码:148 / 152
页数:5
相关论文
共 50 条
  • [41] Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
    Ghoreschi, Kamran
    Balato, Anna
    Enerback, Charlotta
    Sabat, Robert
    LANCET, 2021, 397 (10275): : 754 - 766
  • [42] Atherosclerotic lesions express mrna for IL-17, IL-17R, IL-23 and IL-23R
    De Oliveira, Romulo Tadeu Dias
    Momoni, Ronei Luciano
    Ferreira, Maria Carolina
    Longui, Larissa Nara Alegrini
    Souza, Jose Roberto Matos
    Fernandes, Juliano De Lara
    Menezes, Fabio Husenonan
    Blotta, Maria Heloisa
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (03) : 26 - 27
  • [43] Erratum: The IL-23–IL-17 axis in inflammatory arthritis
    Erik Lubberts
    Nature Reviews Rheumatology, 2015, 11 : 562 - 562
  • [44] The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
    Tsukazaki, Hiroyuki
    Kaito, Takashi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 19
  • [45] IL-23 and IL-17 in pathogenesis of experimental ocular autoimmunity: requirement for IL-23 may extend beyond its role in sustaining the IL-17 effector response
    Caspi, Rachel
    Silver, Phyllis
    Cua, Daniel
    Chen, Zoe
    Chan, Chi-Chao
    Luger, Dror
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [46] IL-23 and IL-17 in pathogenesis of experimental ocular autoimmunity: Requirement for IL-23 may extend beyond its role in sustaining the IL-17 effector response
    Luger, Dror
    Cua, Daniel
    Chen, Zoe
    Iwokura, Yoichiro
    Bowman, Edward
    Chan, Chi-Chao
    Caspi, Rachel
    CLINICAL IMMUNOLOGY, 2007, 123 : S61 - S61
  • [47] NET Formation in Bullous Pemphigoid Patients With Relapse Is Modulated by IL-17 and IL-23 Interplay
    Giusti, Delphine
    Bini, Estela
    Terryn, Christine
    Didier, Kevin
    Le Jan, Sebastien
    Gatouillat, Gregory
    Durlach, Anne
    Nesmond, Stephane
    Muller, Celine
    Bernard, Philippe
    Antonicelli, Frank
    Bach Nga Pham
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [48] Role of the IL-23/IL-17 Axis in Crohn's Disease
    Siakavellas, Spyros I.
    Bamias, Giorgos
    DISCOVERY MEDICINE, 2012, 14 (77) : 253 - 262
  • [49] IL-23/IL-17 immunity as a hallmark of Crohn's disease
    Holtta, Veera
    Klemetti, Paula
    Sipponen, Taina
    Kociubinski, Guillermo
    Westerholm-Ormio, Mia
    Solo, Horri
    Rasanen, Loura
    Kolho, Kaija-Leena
    Farkkila, Martti
    Savilahti, Erkki
    Vaarala, Outi
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (09) : 1175 - 1184
  • [50] NO DEMONSTRABLE EFFECT OF IL-23 RECEPTOR VARIANTS ON CLINICAL MEASURES AND IL23/IL-17 LEVELS IN ANKYLOSING SPONDYLITIS
    Nossent, J.
    Johnsen, S.
    Bakland, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 647 - 648